GlassScriptPhysician profile
Ashley Michaux
NPI 1184049058
$4,568.97
in general payments reported to CMS, 2019-2025
10 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $906 · 2022: $749 · 2023: $1,155 · 2024: $595 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,913.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,448.91 | 2023-2025 | |
| Allergan, INC. | $958.14 | 2021-2022 | |
| Galderma Laboratories, L.P. | $712.05 | 2021-2024 | |
| Merz North America, INC. | $123.24 | 2022-2024 | |
| Revance Therapeutics, INC. | $103.85 | 2024 | Daxxify |
| Vertex Pharmaceuticals Incorporated | $100.44 | 2025 | |
| Davol INC. | $56.39 | 2021-2023 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $24.47 | 2022 | |
| Ethicon US, LLC | $21.48 | 2025 | Stratafix |
| Solta Medical, A Division of Bausch Health US, LLC | $20.00 | 2024 | Clear & Brilliant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Michaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.